These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7539670)

  • 1. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
    Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG response to an outer membrane porin protein of Burkholderia cepacia in patients with cystic fibrosis.
    Lacy DE; Smith AW; Lambert PA; Peckham D; Stableforth DE; Smith EG; Desai M; Weller PH; Brown MR
    FEMS Immunol Med Microbiol; 1997 Feb; 17(2):87-94. PubMed ID: 9061354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
    Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
    J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
    Aronoff SC; Quinn FJ; Stern RC
    Pediatr Pulmonol; 1991; 11(4):289-93. PubMed ID: 1722035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
    Aronoff SC; Stern RC
    J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
    Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
    Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.
    Butler SL; Nelson JW; Poxton IR; Govan JR
    FEMS Immunol Med Microbiol; 1994 May; 8(4):285-92. PubMed ID: 7520313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining potential targets for immunotherapy in Burkholderia cepacia infection.
    Burnie JP; al-Wardi EJ; Williamson P; Matthews RC; Webb K; David T
    FEMS Immunol Med Microbiol; 1995 Jan; 10(2):157-64. PubMed ID: 7536517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa.
    Kubesch P; von Specht BU; Tümmler B
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):395-410. PubMed ID: 3146171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C
    Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection.
    Cochrane DM; Brown MR; Anwar H; Weller PH; Lam K; Costerton JW
    J Med Microbiol; 1988 Dec; 27(4):255-61. PubMed ID: 3143837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic analysis of Pseudomonas aeruginosa and Pseudomonas cepacia GroEL proteins and demonstration of a lipopolysaccharide-associated GroEL fraction in P. aeruginosa.
    Jensen P; Fomsgaard A; Shand G; Hindersson P; Høiby N
    APMIS; 1993 Aug; 101(8):621-30. PubMed ID: 7692893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells.
    Morrin M; Reen DJ
    J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
    J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.
    Ward KH; Anwar H; Brown RW; Wale J; Gowar J
    J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK
    Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
    Hancock RE; Mouat EC; Speert DP
    J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.